Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, an... Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features. Show more
STAMFORD, Conn., July 11, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc.ย (Nasdaq: CARA) today announced that it has engaged Piper Sandler & Co. to act as its financial advisor for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0145 | 4.99827645639 | 0.2901 | 0.323 | 0.278 | 511328 | 0.30374065 | CS |
4 | 0.0346 | 12.8148148148 | 0.27 | 0.3685 | 0.26 | 895786 | 0.31473967 | CS |
12 | -0.0354 | -10.4117647059 | 0.34 | 0.3685 | 0.245 | 521245 | 0.30099286 | CS |
26 | -0.3849 | -55.8230601885 | 0.6895 | 0.73 | 0.24 | 656475 | 0.33710346 | CS |
52 | -0.6686 | -68.7011919441 | 0.9732 | 1.31 | 0.24 | 668059 | 0.5601661 | CS |
156 | -12.9454 | -97.7011320755 | 13.25 | 13.965 | 0.24 | 646327 | 4.61050903 | CS |
260 | -24.1954 | -98.7567346939 | 24.5 | 29.6473 | 0.24 | 690308 | 9.83545815 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.